The Department of Veterans Affairs (VA) National Acquisition Center awarded this single-award Indefinite Delivery Contract (IDC) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, to provide Diclofenac NA 1% Gel. The contract has a base year from June 15, 2020 to June 14, 2021 and four 1-year option periods, with a total ceiling value of $52,330,802.25.
The contract was awarded as an unrestricted procurement to supply the VA, Department of Defense, Bureau of Prisons, and Indian Health Service with over 3 million tubes of 100g Diclofenac NA 1% Gel annually through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs. Exelan Pharmaceuticals, which specializes in providing branded and generic medications to federal healthcare agencies, will be the sole supplier for this contract. Funding for the IDC primarily comes from the VA National Acquisition Center.
Generated 9/20/24, 9:04 AM